Bloomage BioTechnology
About:
Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Website: http://www.bloomagebio-tech.com/e/index.php
Twitter/X: bloomagebiotech
Top Investors: GIC, Larry Zhao
Description:
Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.
$95.3M
$50M to $100M
Beijing, Beijing, China
1998-01-01
info(AT)biobloomage.com
501-1000
2023-09-29
Public
© 2025 bioDAO.ai